LSTA
Lisata Therapeutics Inc.
NASDAQ: LSTA · HEALTHCARE · BIOTECHNOLOGY
$3.12
-3.11% today
Updated 2026-04-30
Market cap
$28.18M
P/E ratio
—
P/S ratio
165.77x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
Lisata Therapeutics Inc. (LSTA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+18.8%
Last 4 quarters
Revenue YoY growth
-90.0%
Most recent quarter
EPS YoY growth
+39.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-12.0%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.33 | +46.5% | $4.39 | $4.10 | -6.6% |
| 2025-11-06 | $-0.49 | +16.9% | $2.34 | $2.06 | -12.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.63 | $-0.33 | +46.5% | $100000.00 | -90.0% |
| 2025-09-30 | $-0.59 | $-0.49 | +16.9% | — | — |
| 2025-06-30 | $-0.64 | $-0.54 | +15.6% | $70000.00 | — |
| 2025-03-31 | $-0.53 | $-0.55 | -3.8% | — | — |
| 2024-12-31 | $-0.76 | $-0.55 | +27.6% | $1.00M | — |
| 2024-09-30 | $-0.77 | $-0.59 | +23.4% | — | — |
| 2024-06-30 | $-0.76 | $-0.61 | +19.7% | — | — |
| 2024-03-31 | $-0.72 | $-0.65 | +9.7% | — | — |
| 2023-12-31 | $-0.89 | $-0.66 | +25.8% | — | — |
| 2023-09-30 | $-0.93 | $-0.65 | +30.1% | — | — |
| 2023-06-30 | $-0.70 | $-0.50 | +28.6% | — | — |
| 2023-03-31 | $-0.81 | $-0.77 | +4.9% | — | — |
Frequently asked questions
Has Lisata Therapeutics Inc. beaten earnings estimates?
Lisata Therapeutics Inc. has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +18.8% over the last 4 quarters.
How does LSTA stock react to earnings?
LSTA stock has moved an average of -9.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Lisata Therapeutics Inc.'s revenue growth rate?
Lisata Therapeutics Inc. reported year-over-year revenue growth of -90.0% in its most recent quarter, with EPS growing +39.2% year-over-year.